Downstream CMC Lead Emerging Modalities

Alnylam Pharmaceuticals is seeking an Associate Director to lead downstream development for emerging modalities, with emphasis on antibody purification and Antibody Oligo Conjugate purification. You will guide CMC strategy and partner with CDMOs to advance programs from preclinical to Phase I.

You will design scalable purification processes, define control strategies, and contribute to regulatory submissions while coordinating with cross-functional teams across research, analytical development,

We would love to welcome a new Downstream CMC Lead for Emerging Modalities to our team in Cambridge, MA, United States.

Please review the full job details above before applying.

If your experience matches this role, we encourage you to apply.

All applications are reviewed carefully by our team.

The position is based in Cambridge, MA, United States.

This opportunity is part of our work in Bio & Pharmacology & Health, Management & Operations.